On November 14, 2014, Lipocine Inc. announced that it has terminated the employment of Dr. Srinivasan Venkateshwaran, Chief Technology Officer and Vice President Research & Development, and Gerald Simmons, Corporate Business Development Officer.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.875 USD | -0.36% | +3.92% | +146.95% |
May. 09 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
May. 09 | Lipocine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+146.95% | 36.9M | |
+15.32% | 121B | |
+13.46% | 107B | |
-5.70% | 24.82B | |
+1.72% | 22.48B | |
-10.09% | 18.32B | |
-42.28% | 16.33B | |
-15.83% | 15.31B | |
+2.91% | 14.08B | |
+25.17% | 11.74B |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.
- Lipocine Inc. Announces Board Resignations